Executive Director, Lifecycle Leader

🕒 il y a 3 mois

🇺🇸 États-Unis – Télétravail

💵 $290 000 - $330 000 / an

⏰ Temps Plein

🟠 Senior

👔 Directeur

👻 Score fantôme 16%

Ce que ça veut dire : la probabilité que cette offre reste ouverte sans recrutement actif.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Configurer une alerte email pour les nouveaux emplois

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV

Iovance Biotherapeutics, Inc.

Site WebLinkedInTous les Emplois

501 - 1000 employés

Fondée en 2014

🏥 Santé

🧬 Biotechnologie

💊 Pharmaceutique

Healthcare • Biotechnology • Pharmaceuticals

Iovance Biotherapeutics, Inc. est à la pointe d'une approche révolutionnaire pour traiter le cancer en exploitant la capacité du système immunitaire humain à reconnaître et attaquer diverses cellules cancéreuses chez chaque patient. La société se concentre sur l'immunothérapie basée sur les cellules T, plus précisément sur la thérapie des lymphocytes infiltrant les tumeurs (TIL), qui consiste à revitaliser les TIL d'un patient pour lutter contre le cancer. La thérapie TIL d'Iovance fait l'objet d'essais cliniques sur plusieurs cancers à tumeurs solides avancées. De plus, l'entreprise développe des thérapies TIL génétiquement modifiées et explore les applications potentielles de la thérapie par lymphocytes du sang périphérique (PBL) pour les cancers du sang. En tant que leader de la thérapie cellulaire, Iovance possède un centre de thérapie cellulaire de pointe à Philadelphie pour la fabrication de leurs thérapies en utilisant un GMP propriétaire. L'entreprise est à l'avant-garde du développement de traitements contre le cancer, personnalisés et spécifiques à chaque patient.

Description

• The LCL is responsible for shaping the program's cross-functional vision, strategic context, and lifecycle plan (LCP) for both current and future business opportunities. • The LCL, in partnership with the Program Manager, will work with leadership & SMEs (subject matter experts) to build out appropriate internal ways of working to enable best practices around development of data driven recommendations, decision making and communication. • As the single point of accountability in a cross-functional team, the LCL ensures timely delivery and manages the associated execution plan and milestones, closely aligning them with the approved LCP. • The LCL oversees integration across Iovance involving multiple stakeholders to ensure optimal program execution in line with program strategy and LCP. • Collaborating with functional team leaders, the LCL fosters alignment across the different sub -teams to ensure execution will achieve team and corporate goals (Commercial Team, Development Team, Regulatory Team etc.) • Serving as a point of triage, the LCL facilitates clear decision-making by incorporating cross-functional input to address high-impact issues. This involves co-creating solutions to complex challenges in real time. • The LCL leads the team in framing program needs and develops a range of options and recommendations for presentation to the Executive Leadership Team (ELT). The LCL ensures transparent communication with senior leadership, highlighting relevant scenarios, assumptions, and risks to inform decision-making and trade-offs. The LCL also represents the enterprise mindset and ensures all relevant functional perspectives have been considered. • The LCL ensures the inclusion of subject matter experts (SMEs) and situational members in discussions, guided by a predefined agenda set with guidance from the Program Manager. • The LCL is accountable to the ELT for program recommendations and frames them within the context of the broader portfolio. • The LCL is accountable for day-to-day management of the program to ensure all established deliverables with high program impact remain on track and in line with program strategy. • The LCL is responsible for ensuring the health of the team, creating a highly functional environment with collaborative ways of working where debate and honest feedback are encouraged • Other responsibilities to consider: Risk identification and mitigation planning; ensuring financial stewardship of approved and recommended projects; clear communication throughout organization of key milestones, deliverables and progress; ensure appropriate resourcing of functions to achieve program goals and vision.

🎯 Exigences

• Bachelor's degree in a scientific discipline; advanced or professional degree highly desirable (e.g., PhD, MD, or MBA). • 15+ years of bio-pharmaceutical industry experience with at least 5 years of relevant work experiences in the biotech/pharmaceutical industry as a Lifecycle Leader or Program Team Leader. • Must demonstrate strong knowledge of the overall drug development process relevant to biotech/ pharmaceutical companies; commercial launch experience and a depth of experience with drug development is required. • Experience working with or on program strategy teams required.

🏖️ Avantages

• Iovance is committed to cultivating and offering a diverse and inclusive work environment. • Equal-opportunity employer. • Reasonable accommodations may be made upon request to enable individuals to perform essential functions.